Authors: Skirnisdottir, I Sorbe, B Seidal, T

Citation: I. Skirnisdottir et al., The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma, INT J GYN C, 11(2), 2001, pp. 119-129

Authors: Skirnisdottir, I Sorbe, B Seidal, T

Citation: I. Skirnisdottir et al., P53, bcl-2, and bax: Their relationship and effect on prognosis in early stage epithelial ovarian carcinoma, INT J GYN C, 11(2), 2001, pp. 147-158

Authors: Skirnisdottir, I Sorbe, B Karlsson, M Seidal, T

Citation: I. Skirnisdottir et al., Prognostic importance of DNA ploidy and p53 in early stages of epithelial ovarian carcinoma, INT J ONCOL, 19(6), 2001, pp. 1295-1302

Authors: Sorbe, B

Citation: B. Sorbe, Consolidation treatment of ovarian carcinoma, stage III, at complete surgical remission after induction chemotherapy, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 295-301

Authors: Trope, C Hogberg, T Kaern, J Bertelsen, K Bjorkholm, E Boman, K Himmelmann, A Horvath, G Jacobsen, A Kuoppola, T Vartianen, J Lund, B Onsrud, M Puistola, U Salmi, T Scheistroen, M Sandvei, R Simonsen, E Sorbe, B Tholander, B Westberg, R

Citation: C. Trope et al., Long-term results from a phase II study of single agent paclitaxel (Taxol (R)) in previously platinum treated patients with advanced ovarian cancer: The Nordic experience, ANN ONCOL, 9(12), 1998, pp. 1301-1307